(19)

(11)

EP 4 218 790 A8

(12)	CORRECTED EUROPEAN PATENT APPLICATION
	Note: Bibliography reflects the latest situation

(15) Correction information: Corrected version no 1 (W1 A1) (48) Corrigendum issued on: 04.10.2023 Bulletin 2023/40 (43) Date of publication: 02.08.2023 Bulletin 2023/31 (21) Application number: 22216383.4 (22) Date of filing: 07.12.2016

(51) International Patent Classification (IPC):  A61K 38/12(2006.01) A61P 37/02(2006.01) A61P 7/00(2006.01) A61M 5/30(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0019; A61K 38/12; A61P 7/00; A61P 37/02

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (30) Priority: 16.12.2015 US 201562268360 P 03.05.2016 US 201662331320 P 08.06.2016 US 201662347486 P (62) Application number of the earlier application in accordance with Art. 76 EPC: 20157916.6 / 3685847 16823378.1 / 3389692 (71) Applicant: RA Pharmaceuticals, Inc. Cambridge, MA 02140 (US)

(72) Inventors: Demarco, Steven James Boxford, MA, 01921 (US) Hoarty, Michelle Denise Billerica, MA, 01821 (US) Parker, Grace Victoria Medford, MA, 02155 (US) Ricardo, Alonso Winchester, MA, 01890 (US) Tobe, Sylvia Cambridge, MA, 02139 (US) Treco, Douglas A. Arlington, MA, 02476 (US) (74) Representative: Hoffmann Eitle  Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München 81925 München (DE)

Remarks: This application was filed on 23-12-2022 as a divisional application to the application mentioned under INID code 62. Remarks: Claims filed after the date of receipt of the application (Rule 68(4) EPC).